Dehaier Medical to Present at 2013 China Sleep Medicine Congress
11 July 2013 - 10:30PM
Dehaier Medical Systems Ltd. (Nasdaq:DHRM)
("Dehaier" or the "Company"), an emerging leader in the
development, assembly, marketing and sale of medical devices and
homecare medical products, today announced that it will present its
newly developed Morpheus Ox System at the 2013 the Fourth China
Sleep Medicine Congress in Wuxi city, Jiangsu Province from July 12
-14 2013.
The Morpheus Ox System is a cost-effective, portable home sleep
diagnostic and monitoring solution that enables the diagnosis of
sleep disorders using a standard oximeter recording plethysmograph
signal. By collecting and recording the physiological data from
patients who wear the watch-sized device at home, the advanced
automatic sleep scoring software generates an accurate and reliable
sleep study diagnosis, including Apnea Hypopnea Index (AHI),
sleep/wake time, and Cheyne-Stokes breathing patterns. The new
generation Morpheus Ox is a comprehensive platform that manages a
cost-effective sleep services operation, including patient
electronic medical records, cardiac and sleep diagnostics outcomes
and complete workflow management. The web-based automatic scoring
and data management facilitates operational efficiency and
maximizes growth potential by giving users valuable and timely
clinical information to improve patient treatment.
Mr. Ping Chen, Chairman and Chief Executive Officer
of Dehaier Medical, stated, " Morpheus OX provides a revolutionary
solution to sleep diagnosis and we explored a unique business model
to cater to China sleep disorder and diagnosis market. We believe
that Morpheus Ox will lead to a close relationship among patients,
doctors and hospitals and facilitate to establish a sustainable
market. We are confident that the state-of-the-art system would be
an innovative success in domestic sleep diagnosis market going
forward. By presenting Morpheus Ox at the Congress, we expect to
have more people know about the system and seize great chances
lying ahead of us."
The Chinese Sleep Medicine Congress is one of China's
most influential and comprehensive sleep medicine meetings,
sponsored by the Chinese Medical Doctor Association and co-hosted
by China Sleep Medicine Expert Committee and China Sleep Medicine
League.
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including respiratory and
oxygen homecare medical products. The company develops and
assembles its own branded medical devices and homecare medical
products from third-party components. The company also distributes
products designed and manufactured by other companies, including
medical devices from IMD (Italy), Welch Allyn (USA), HEYER
(Germany), Timesco (UK), eVent Medical (US) and JMS (Japan).
Dehaier's technology is based on six patents, nine software
copyrights and proprietary technology. More information may be
found at http://www.dehaier.com.cn
Forward-looking Statements
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, government approvals
or performance, and underlying assumptions and other statements
that are other than statements of historical facts, including in
particular any implications regarding the Dehaier's attendance of
China Sleep Medicine Congress. These statements are subject to
uncertainties and risks including, but not limited to, product and
service demand and acceptance, changes in technology, economic
conditions, the impact of competition and pricing, government
regulation, future developments in payment for and demand for
medical equipment and services, implementation of and performance
under the joint venture agreement by all parties, and other risks
contained in reports filed by the company with the Securities and
Exchange Commission. All such forward-looking statements, whether
written or oral, and whether made by or on behalf of the company,
are expressly qualified by the cautionary statements and any other
cautionary statements which may accompany the forward-looking
statements. In addition, the company disclaims any obligation to
update any forward-looking statements to reflect events or
circumstances after the date hereof.
CONTACT: Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn
Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jul 2023 to Jul 2024